Tag:
bardoxolone
Latest Headlines
Latest Headlines
UPDATED: Abbott bets $400M on mega-blockbuster future for Reata program
Abbott ( $ABT ) has essentially doubled down on its high-stakes gamble that Reata Pharmaceuticals has the inside track on improving renal function in patients with chronic kidney disease, agreeing to
Abbott spotlights blockbuster hopefuls in pitching spinoff
Abbott Labs' pharma-designated CEO, Richard Gonzalez, spent a good part of Friday painting a bright future for Abbott's proposed spinoff. Abbott, of course, already has a multibillion-dollar
Abbott deals beef up late-stage platform of blockbuster contenders
Abbott Labs ( $ABT ) doesn't do a lot of deals compared with some of its Big Pharma rivals. But when the company inks a deal, it isn't afraid of using some big numbers. Abbott pledged $450 million just
Reata scores $450M in quick cash from Abbott pact
Irving, TX-based Reata Pharmaceuticals snared a treasure trove of $450 million in upfront and near-term cash from Abbott Labs in exchange for the ex-U.S. licensing rights to the mid-stage chronic
